A New, Single Delivery Therapy Could Fight Many Forms Of Cancer
Mohammad Ali (@ChaudhryMAli88) Published September 27, 2019 | 12:05 PM
Using mouse models, researchers from the University of California Los Angeles have developed an experimental therapy that boosts the levels of a type of immune cell that appears capable of fighting several forms of cancer
Islamabad (UrduPoint / Pakistan Point News - 27th September, 2019) Using mouse models, researchers from the University of California Los Angeles have developed an experimental therapy that boosts the levels of a type of immune cell that appears capable of fighting several forms of cancer.Researchers believe that a potent form of immune cell could be a way forward in cancer therapy.Invariant natural killer T (iNKT) cells are a type of powerful immune cell capable to fighting many different "intruders," including cancer cells.Human bodies hold relatively few of these cells, limiting how much they can contribute to suppressingtumor growth.
However, their potency makes them ideal candidates for innovative anticancer immunotherapy.And this is precisely what a team of researchers from the University of California Los Angeles (UCLA) has set out to do.
Using mouse models of different forms of cancer, the scientists have tested a new therapy that boosts the potential of iNKT cells.The researchers detail their experiments in a study paper that now appears in the journal Cell Stem Cell."What's really exciting is that we can give this treatment just once, and it increases the number of iNKT cells to levels that can fight cancer for the lifetime of the animal."In the study paper, the researchers explain that what makes these immune cells special is that unlike other immune cells they "have the remarkable capacity to target multiple types of cancer" at once.By looking at previous clinical studies, the researchers also found that people with cancer who naturally have higher levels of iNKT cells tend to live for longer than peers with lower levels."They are very powerful cells, but they're naturally present in such small numbers in the human blood that they usually can't make a therapeutic difference," Yang explains.Through their recent experiments, the researchers wanted to create a form of therapy that would stimulate the body to produce more iNKT cells on a permanent basis.
The team was hoping to find a "single-delivery" therapy, so to speak.To do so, the scientists genetically engineered a form of stem cells hematopoietic stem cells from bone marrow to develop into iNKT cells.
They named the resulting cells "hematopoietic stem cell-engineered invariant natural killer T cells" (HSC-iNKT).Then, to see if the cells worked as they intended, the researchers tested HSC-iNKT cells in mice to which they had transferred both human bone marrow and cancers of human origin, including multiple myeloma (a form of blood cancer), and melanoma (solid tumors).The team found that the experiment was successful: the HSC-iNKT cells were able to differentiate and form iNKT cells, and this process continued for the rest of the rodents' lives.
Not only that but the mice they had treated also presented effective suppression of both multiple myeloma and melanoma tumor growth."One advantage of this approach is that it's a one time cell therapy that can provide patients with a lifelong supply of iNKT cells," says Yang.The researchers also specify that iNKT cells accounted for 60% of the total T cell count in the mice that had the HSC-iNKT therapy in comparison to the control mice, which represents a significant boost.Moreover, the investigators say that they can control how many iNKT cells the mice produce by simply tweaking the HSC-iNKT cell programming.Although this treatment is, as yet, only at the level of preclinical research, and it remains unclear whether this same process would be as effective in humans, the UCLA investigators believe that the premise is promising.All the more so, they note, since the procedure for transplanting stem cells into bone marrow in humans is already in place, and doctors are using it for other therapeutic interventions.
Recent Stories
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 18 April 2024
Today Gold Rate in Pakistan 18 April 2024
Saka and Odegaard start for Arsenal, Guerreiro in Bayern midfield
Qatar PM says re-evaluating Israel-Hamas mediation role
Govt spokesperson terms allegations of PTI's Marwat against Saudi Arabia 'heinou ..
Minister appreciate UAE’s support for Pakistan economic challenges
Manchester City v Real Madrid Champions League starting line-ups
MIGA's support Pakistan in attracting foreign investments: Federal Minister for ..
Walker returns to captain Man City for Real Madrid clash
Action taken against price list violations in Khanewal district
DC chairs review meeting of DEG
Turkey accuses Israel's Netanyahu of using war 'to stay in power'
More Stories From Health
-
World Hemophilia Day observed to underscore importance of providing comprehensive care
11 hours ago -
Six in a family with heart on the 'right side'
11 hours ago -
Diabetic disease increasing rapidly : Dr. Noor Elahi Memon
14 hours ago -
World Hemophilia Day observed
16 hours ago -
ATC dismisses bail petition of doctor involved in illegal kidneys transplant
9 days ago -
Dr. Shehzad warns against deviation from WHO guidelines on anti-smoking
9 days ago
-
Health activists express concerns over attempts to derail tobacco control
11 days ago -
UHS declares MBBS first prof, MS urology exam results
20 days ago -
Increased diagnostic testing for drug resistance
26 days ago -
IRD releases groundbreaking results of end TB programme
28 days ago -
Increased diagnostic testing for drug resistance TB will enhance patients’ treatment outcome
1 month ago -
JRF to provide insulin to underprivileged diabetic patients
1 month ago